Skip to content
  • Newsroom
  • Events
  • Contact
  • Home
  • Patients

    I need help with...

    • Understanding pelvic masses

      What is an adnexal mass and does it mean I have cancer?

    • Treatment plan options

      What testing is available to help map my treatment plan?

    • What to expect

      What do I need to know if my doctor orders one of your test kits?

    • Ongoing support

      Where can I turn for additional support?

    About Our tests

    Which test should I use?

    How do I tell my provider to order a test?

    Patient Resources

    Insurance & Billing

    Financial Assistance

    Pay a Bill

    Contact Us

  • Providers

    I need help with...

    • Assessing a pelvic mass

      What are the testing options available for pelvic masses?

    • Testing an indeterminate or likely benign pelvic mass

      Which test should I use if an unknown mass has been identified?

    • Testing a pelvic mass with planned surgery

      Which test should I use to assess my risk of malignancy before surgery?

    • How does the test work?

      What additional services do you provide?

    Order Test Kits

    Ova1Plus®

    OvaWatch®

    Scientific Publications

    FAQs

    Specimen Collection

    Clinical Studies

    Your patient may qualify for a clinical trial, learn more →

    Provider Resources

    Order Test Kits

    Order Patient Materials

    Download Test Requisition Form

    Insurance & Billing

    Provider Events 

  • Our Products
    • OvaWatch®
    • Ova1Plus®
  • About Us
    • About Us
    • Leadership
    • Careers
  • Research & Development
    • Pipeline
    • Clinical Study
    • Research and Professional Guidelines
  • Investors
    • Investor Overview
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Stock Information
    • Corporate Governance

Archive for July 2025

Aspira Women’s Health Announces Appointment of Jane Pine Wood to the Board of Directors

By Gina | July 15, 2025

AUSTIN, TX / ACCESS Newswire / July 15, 2025 / Aspira Women’s Health Inc. (“Aspira” or the “Company”) (QTCQB:AWHL), an AI enhanced bio-analytical based women’s health company focused on delivering the leading tools critical to gynecologic disease diagnostics and disease management, today announced the appointment of Jane Pine Wood to the Board of Directors, effective July 11, 2025.…

Read More

Recent Posts

  • Aspira Announces Second Quarter 2025 Financial Results and Provides Business Update
  • Aspira Women’s Health Announces Appointment of Jane Pine Wood to the Board of Directors
  • Aspira Women’s Health Partners with Dorsata to Offer Access to 300+ Women’s Health Practices, 1.5 Million + New Patients
  • Aspira Women’s Health Provides Update on ARPA-H Sprint Program Partnership to Advance Women’s Health
  • Aspira Announces First Quarter 2025 Financial Results and Provides Business Update

Recent Comments

    Archives

    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024

    Categories

    • Press Release
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Search

    Footer

    Have a question?

    Tel: 844-ASPIRA1 (844-277-4721)

    Fax: 866-283-3634

    12117 Bee Caves Road
    Building III, Suite 100
    Austin, TX 78738

    Investors

    Investor Overview

    Events & Presentations

    SEC Filings

    Corporate Governance

    Stock Information

    Providers & Practices

    Provider Overview

    Research and Professional Guidelines

    Clinical Studies

    Pipeline

    Patients & Individuals

    Patient Overview

    Insurance & Billing

    Bill Pay

    Resources

    News

    Educational Events

    FAQs

    About

    About Aspira

    Leadership

    Licensure & Legal

    Code of Conduct

    Aspira Synergy

    © 2023-2025 Aspira Women's Health. All Rights Reserved.

    Privacy Policy. Terms of Use.

    • Home
    • Patients
    • Providers
    • Our Products
      • OvaWatch®
      • Ova1Plus®
    • About Us
      • Our Story
      • Leadership
      • Careers
    • Research and Development
      • Pipeline
      • Clinical Study
      • Research and Professional Guidelines
    • Investors
      • Investor Overview
      • News
      • Events & Presentations
      • SEC Filings
      • Stock Information
      • Corporate Governance